Advertisement
Advertisement
SRTA
S
Strata Critical Medical, Inc. Class A Common Stock
4.75
USDSponsored
+0.34
+7.84%
Feb 06, 15:58 UTC -5
Closed
After-Market
4.74
0.00
-0.11%
SRTA Earnings Reports
Positive Surprise Ratio
SRTA beat 8 of 15 last estimates.
53%
Next Report
Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
$61.56M
/-$0.02
Implied change from Q3 25 (Revenue/ EPS)
+24.87%
/-60.00%
Implied change from Q4 24 (Revenue/ EPS)
+13.25%
/-84.62%
Strata Critical Medical, Inc. Class A Common Stock earnings per share and revenue
On Nov 10, 2025, SRTA reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.02 USD, resulting in a -96.08% surprise. Revenue reached 49.30 million, compared to an expected 44.88 million, with a 9.84% difference. The market reacted with a +9.48% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 61.56 million USD, implying an decrease of -60.00% EPS, and increase of 24.87% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
What were Strata Critical Medical, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Strata Critical Medical, Inc. Class A Common Stock reported EPS of -$0.05, missing estimates by -96.08%, and revenue of $49.30M, 9.84% above expectations.
How did the market react to Strata Critical Medical, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 9.48%, changed from $4.43 before the earnings release to $4.85 the day after.
When is Strata Critical Medical, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 11, 2026.
What are the forecasts for Strata Critical Medical, Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Strata Critical Medical, Inc. Class A Common Stock is expected to report EPS of -$0.02 and revenue of $61.56M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement